ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARP Annual Meeting 2019

Abstract Number: 2276

Impact of the Healthy Outcomes in Pregnancy with SLE Through Education of Providers (HOP-STEP) Program: A Mixed Methods Approach

Ravyn Njagu1, Amanda Eudy 2, Amanda Snyderman 1, Lisa Criscione-Schreiber 2 and Megan Clowse 2, 1Duke University, Durham, NC, 2Duke University, Durham

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARP Annual Meeting 2019

Keywords: medical education and Contraception, pregnancy, SLE

Session Information

Date: Tuesday, November 12, 2019

Title: Reproductive Issues In Rheumatic Disorders Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: While centers have worked to optimize lupus pregnancy outcomes, additional efforts are required to have a broader impact on lupus pregnancy outcomes. The goal of this educational initiative was to create a multi-dimensional intervention to equip community rheumatologists with the needed skills, attitudes, and confidence to effectively manage contraceptive decisions and improve pregnancy outcomes.

Methods: Design of the HOP-STEP program included a needs assessment followed by development of a comprehensive program using mixed modalities to create lasting practice change. The program included an in-person didactic, a simulated clinical experience, training in use of a comprehensive handout to guide open contraception and pregnancy conversations, and access to a website with additional resources including certified medical education. We assessed program impact using a mixed methods approach.  A survey was emailed to 149 individuals before and after workshop completion. All attendees were invited to be interviewed about their experience integrating HOP-STEP resources into practice.

Results: We analyzed 68 pre-surveys (response rate 46%, 93% women, 66% attending-level rheumatologists) and 55 post-surveys (response rate 37%, 96% women, 64% attending-level rheumatologists). For qualitative analysis, 8 interviews were completed until thematic saturation was achieved.   At program completion, the percentage of providers reporting a systematic approach to preparing a woman with lupus for pregnancy increased from 45.6% to 94.6%; p< 0.0001. When assessed using confidence scale (0=no confidence, 100=high confidence), median provider confidence in helping women with lupus choose appropriate contraception increased from 59 to 89; p< 0.0001 and confidence in choosing pregnancy compatible medications increased from 66 to 91; p< 0.0001.   While participants demonstrated limited change in contraceptive knowledge, an emerging theme was use of the HOP-STEP contraception handout:   “I’m not really comfortable recommending birth control method[s], but it was interesting to see that whole [contraception] chart…it did increase my confidence because I could just cheat and look at it and show [patients] visually.”   After the program more providers correctly identified azathioprine (74% to 98%, p < 0.0001) and tacrolimus (46% to 91%, p < 0.0001) as pregnancy compatible and mycophenolate as teratogenic (84% to 96%, p=0.04). Regarding comparative teratogenicity, a common theme was elucidated by the following quote:   “That Cellcept is as high as it is on the list of drugs that are very bad for fetuses…I didn’t realize that quite as much as I should’ve, everybody knows about methotrexate, but the fact that Cellcept is probably even worse than methotrexate I was not aware of…”

Conclusion: We have demonstrated successful creation and delivery of a new multi-modal educational program, HOP-STEP, that has improved provider confidence, skills, and knowledge in managing women with lupus who desire pregnancy. Providers may now access a unique curriculum and resources that encourage providers and patients to have open and accurate conversations about pregnancy, creating lasting clinical change.


Disclosure: R. Njagu, None; A. Eudy, GSK, 2; A. Snyderman, GSK, 2; L. Criscione-Schreiber, None; M. Clowse, GSK, 2, UCB, 5.

To cite this abstract in AMA style:

Njagu R, Eudy A, Snyderman A, Criscione-Schreiber L, Clowse M. Impact of the Healthy Outcomes in Pregnancy with SLE Through Education of Providers (HOP-STEP) Program: A Mixed Methods Approach [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/impact-of-the-healthy-outcomes-in-pregnancy-with-sle-through-education-of-providers-hop-step-program-a-mixed-methods-approach/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-the-healthy-outcomes-in-pregnancy-with-sle-through-education-of-providers-hop-step-program-a-mixed-methods-approach/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology